Nothing wasted: Peptidoglycan recycling in mycobacteria
Nothing wasted: Peptidoglycan recycling in mycobacteria
批准号:
BB/N011945/1
负责人:
Patrick Moynihan
金额:
$38.28万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --
中文摘要
结核分枝杆菌是一个活生生的悖论。在细菌中,它拥有最复杂和富含碳的单一细胞壁之一,但它在人类肺部绝对营养不良的环境中茁壮成长。考虑到分枝杆菌细胞壁的成分是天然免疫系统的有效触发因素,这一点更加令人印象深刻。因此,为了支持宿主的稳定生长,这些细菌必须以极高的效率利用其可用的营养物质,并能够隐藏自己以躲避免疫系统。分枝杆菌细胞壁最里面的成分是一种复杂的大分子,称为肽聚糖(PG)。虽然教科书上的PG插图表明它是一个静态的袋状结构,但实际上它是一个高度修饰的动态分子,可以防止细胞爆炸,同时赋予它形状。在细菌的整个生命周期中,PG必须不断和仔细地切割和重塑,以支持生长和分裂。研究人员对PG的研究由来已久,主要是因为它的本质。事实上,第一种临床抗生素青霉素专门针对PG的生物合成。虽然这种生物合成已经被理解了很多年,但对于PG建成后会发生什么,人们知之甚少。对于结核分枝杆菌的PG来说更是如此,它是一种全球性的病原体,也是传染病中第二大杀手。例如,一旦裂解酶将分枝杆菌PG片段从细胞壁上切下,它们的命运就一无所知。这是一个重要的问题,因为如上所述,这些PG片段是免疫系统的强大刺激剂,需要大量稀缺的资源来制造。有趣的是,这些相同的PG片段能够触发细菌从其生活方式的休眠阶段复苏。休眠的结核分枝杆菌能够在宿主内持续多年而不被发现,然后产生活跃的感染。这使疾病和相关暴发的控制严重复杂化,因为即使检测到它们,休眠的结核分枝杆菌也具有异常的抗药性。这些观点清楚地表明,需要了解结核分枝杆菌细胞壁碎片的命运。在一些细菌中,已经描述了复杂的PG回收系统,其工作原理是将PG片段带回细胞中重复使用。在迄今为止观察到的所有案例中,这种循环系统对于细菌感染宿主的能力是重要的。尽管如此,在结核分枝杆菌中从未研究过PG回收。这一途径的研究非常重要,因为分枝杆菌PG循环系统的元件很可能是新的抗生素靶标。在这次团契期间,我将使用新的和令人兴奋的技术来证明分枝杆菌回收它们的PG。我将采取一种高分辨率的方法,探索正在回收的PG碎片的精确结构。然后,我将确定PG循环所需的细胞机制,并描述参与该途径的关键蛋白质。最后,我将研究结核病复苏和PG回收之间的关系。这项工作将解决结核分枝杆菌悖论,并展示它如何能够平衡其营养和生长需求与其营养不良的环境和隐藏自己对我们的免疫系统的需要。
英文摘要
Mycobacterium tuberculosis is a living paradox. Amongst bacteria, it possesses one of the single most complex and carbon-rich cell walls and yet it thrives in the decidedly nutrient poor environment of the human lung. This is made even more impressive considering the fact that components of the mycobacterial cell wall are potent triggers of the innate immune system. Therefore, to support stable growth in their host, these bacteria must be exquisitely efficient with their available nutrients and be able to hide themselves from the immune system. The innermost component of the mycobacterial cell wall is a complex macromolecule called peptidoglycan (PG). While textbook illustrations of PG suggest that it is a static bag-like structure, in reality it is a heavily modified and dynamic molecule that prevents the cell from exploding while simultaneously giving it shape. Throughout the life cycle of the bacterium, PG must constantly and carefully be cut and remodeled to support growth and division. Researchers have long studied PG, chiefly because of its essential nature. Indeed, the first clinical antibiotic, penicillin, specifically targets the biosynthesis of PG. While much of this biosynthesis has been understood for many years, relatively little is known about what happens to PG after it is built. This is even truer for the PG of M. tuberculosis, which is a global pathogen and the second leading killer of people amongst infectious diseases. For example, nothing is known about the fate of mycobacterial PG fragments once lytic enzymes have cut them from the cell wall. This is an important question because as mentioned above, these PG fragments are potent stimulators of the immune system and command a great deal of scarce resources to make. Intriguingly, these same PG fragments are capable of triggering resuscitation of the bacterium from the dormant phase of its lifestyle. Dormant M. tuberculosis is capable of persisting undetected for years inside of its host before producing an active infection. This severely complicates control of the disease and associated outbreaks, because even if they are detected, dormant M. tuberculosis are exceptionally antibiotic resistant. These points make it clear that an understanding of the fate of M. tuberculosis cell wall fragments is needed. In some bacteria complex PG recycling systems have been described which work by bringing PG fragments back into the cell to be reused. In all cases observed to-date this recycling system is important to the ability of the bacterium to infect its host. Despite this, PG recycling has never been investigated in M. tuberculosis. It is important that this pathway be investigated because it is very likely that the elements of a mycobacterial PG recycling system are novel antibiotic targets. During this Fellowship I will use new and exciting techniques to demonstrate that mycobacteria recycle their PG. I will take a high-resolution approach by exploring the precise structure of the PG fragments that are being recycled. I will then determine the cellular machinery that is required for PG recycling and characterise the key proteins involved in the pathway. Finally, I will examine the relationship between tuberculosis resuscitation and PG recycling. This work will address the M. tuberculosis paradox and show how it is able to balance its nutritional and growth requirements with its nutrient poor environment and the need to hide itself from our immune system.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface.
通过靶向亚基界界面来抑制分枝杆菌色氨酸合酶。
DOI:
10.1038/s41598-017-09642-y
发表时间:
2017-08-25
期刊:
Scientific reports
影响因子:
4.6
作者:
[Abrahams KA, Cox JAG, Fütterer K, Rullas J, Ortega-Muro F, Loman NJ, Moynihan PJ, Pérez-Herrán E, Jiménez E, Esquivias J, Barros D, Ballell L, Alemparte C, Besra GS]
通讯作者:
Besra GS
DOI:
10.1371/journal.ppat.1006667
发表时间:
2017-10
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[Sychantha D, Jones CS, Little DJ, Moynihan PJ, Robinson H, Galley NF, Roper DI, Dowson CG, Howell PL, Clarke AJ]
通讯作者:
Clarke AJ
DOI:
10.1016/j.celrep.2018.09.004
发表时间:
2018-10-02
期刊:
Cell reports
影响因子:
8.8
作者:
[Turapov O, Forti F, Kadhim B, Ghisotti D, Sassine J, Straatman-Iwanowska A, Bottrill AR, Moynihan PJ, Wallis R, Barthe P, Cohen-Gonsaud M, Ajuh P, Vollmer W, Mukamolova GV]
通讯作者:
Mukamolova GV
DOI:
10.1021/acs.bioconjchem.8b00484
发表时间:
2018-09-19
期刊:
Bioconjugate chemistry
影响因子:
4.7
作者:
[Veerapen N, Kharkwal SS, Jervis P, Bhowruth V, Besra AK, North SJ, Haslam SM, Dell A, Hobrath J, Quaid PJ, Moynihan PJ, Cox LR, Kharkwal H, Zauderer M, Besra GS, Porcelli SA]
通讯作者:
Porcelli SA
The lasting impact of the 2013 Beveridge poster award.
2013 年贝弗里奇海报奖的持久影响。
DOI:
10.1139/cjm-2017-0458
发表时间:
2018
期刊:
Canadian journal of microbiology
影响因子:
2.8
作者:
[Moynihan PJ]
通讯作者:
Moynihan PJ
共 6 条
alpha-Mannan hydrolysing enzymes as drivers of mycobacterial cell surface diversity.
-
批准号:BB/X00841X/1
-
项目类别:Research Grant
-
资助金额:$53.74万
-
财政年份:2023
-
负责人:Patrick Moynihan
-
依托单位:
Peptidoglycan release and recycling in pathogenic mycobacteria.
-
批准号:BB/S010122/1
-
项目类别:Fellowship
-
资助金额:$119.41万
-
财政年份:2019
-
负责人:Patrick Moynihan
-
依托单位:
海外基金